The Evaluation of the Nutritional Status in Patients with Irritable Bowel Syndrome

Year 2021, Volume: 11 Issue: 1, 119 - 126, 31.03.2021

Birsen Yılmaz Gamze Akbulut

https://doi.org/10.33808/clinexphealthsci.646176

Abstract

Objective: Irritable bowel syndrome (IBS) is one of the most common chronic functional diseases of the gastrointestinal tract. There is no organic disorder in IBS. The pathogenesis of IBS is not fully understood. Although the symptoms of IBS patients are mostly diet-related, there are not many studies evaluating nutrient intake. In this study, it was aimed to determine nutrient intake and nutrition habits of IBS patients.

Methods: A total of 70 IBS patients, 52 females and 18 males, were included in the study. Three-day food records were compiled. Besides, foods that reduced symptoms of IBS and foods that caused sitophobia were interrogated in the study.

Results: The mean age of the patients was 37.8±10.03 years and 40% of them were IBS-mixed subtype. Daily intake of energy and some nutrients were found to be similar to the recommended levels. The mean intake of energy, protein, carbohydrate, saturated fatty acid, vitamin B1, vitamin B2, vitamin B6, vitamin B12, calcium, magnesium, phosphorus, iron, copper (p<0.001), total folic acid, carotene, sodium, and potassium (p<0.05) showed statistically significant differences according to gender. It was determined that 85.7% of the patients had sitophobia. In both genders, apricot was the most reported food to have reduced IBS symptoms. The foods causing sitophobia were raw vegetables-fruits (35.7%), spicy foods (34.3%), and legumes (27.1%).

Conclusions: Although IBS avoids consuming certain foods for fear of increasing their symptoms, energy, and nutrient intake is found to be similar to generally recommended levels.

Keywords

irritable bowel syndrome, nutrition, diet, gastrointestinal diseases, nutrition habits

References

• Referans1 Baykan AR, Kasap E, Gerçeker E, Yüceyar, H. Irritable bowel syndrome and genetics. Current Gastroenterology 2012;16:53-55.
• Referans2 Ford AC, Vandvik PO. Irritable bowel syndrome: dietary interventions. Clinical Evidence 2015;7:1-13.
• Referans3 Talley NJ, Zinsmeister A.R, Van Dyke C, Melton LJ. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991;101:927-934.
• Referans4 Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Digestive Diseases and Sciences 1993;38:1569-1580.
• Referans5 Kumano H, Kaiya H, Yoshiuchi K, Yamanaka G, Sasaki T, Kuboki T. Comorbidity of irritable bowel syndrome, panic disorder, and agoraphobia in a Japanese representative sample. The American Journal of Gastroenterology 2004;99:370-376.
• Referans6 Şimşek İ, Şengül B. Irritable bowel syndrome. Actual Medical Journal 2004;9:60-4.
• Referans7 Karaman N, Türkay C, Yönem O. Irritable bowel syndrome prevalance in city center of Sivas. Turk J. Gastroenterol. 2003;14:128-31.
• Referans8 Çelebi S, Acık Y, Deveci SE, et al. Epidemiological features of irritable bowel syndrome in a Turkish urban society. J Gastroenterol Hepatol 2004;19:738-43.
• Referans9 Mansueto P, Seidita A, D'Alcamo A, Carroccio, A. Role of FODMAPs in Patients With Irritable Bowel Syndrome. Nutrition in Clinical Practice 2015;30:665-682.
• Referans10 Gibson PR, Shepherd SJ. Personal view: food for thought--western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesis. Alimentary Pharmacology & Therapeutics 2005;21:1399-1409.
• Referans11 Çelebi F, Akbulut G. Current Dietary Approaches in Bowel Diseases: Low Fermentable Oligo-, Di- and Mono-Saccharides and Polyols (FODMAP) Diet: Review. Turkiye Klinikleri Journal of Gastroenterohepatology 2014;21:43-52.
• Referans12 Halmos EP, Christophersen CT, Bird AR, Shepherd SJ, Gibson PR, Muir JG. Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut 2015;64:93-100.
• Referans13 Mazzawi T, Hausken T, Gundersen D, El-Salhy M. Effect of dietary management on the gastric endocrine cells in patients with irritable bowel syndrome. European Journal of Clinical Nutrition 2015;69:519-524.
• Referans14 Mazzawi T, Gundersen D, Hausken T, El-Salhy M. Increased gastric chromogranin A cell density following changes to diets of patients with irritable bowel syndrome. Molecular Medicine Reports 2014;10:2322-2326.
• Referans15 WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. The Lancet 2004;363: 157-163.
• Referans16 Pekcan G. Determination of nutritional status. Baysal A, Aksoy M, Besler, T, Bozkurt N, Keçecioğlu S, Mercanlıgil SM, Kutluay-Merdol T, Pekcan G, Yıldız E, editors. Diyet el kitabı. 5th edition. Ankara. Hatiboğlu Publisher, 2008. p. 67-141.
• Referans17 BEBİS (version 7.2). Ebispro for windows. Germany: Turkish Version Nutrition Information Systems.
• Referans18 SPSS Inc. (2013). Statistical Package for the Social Sciences. Chicago, IL; USA.
• Referans19 Öbekli T. Assessment of gastroesophageal reflux with impedance catheter in patients with irritable bowel syndrome. Istanbul University, Istanbul Faculty of Medicine, İstanbul, Master Thesis. 2014. p.25.
• Referans20 Gültepe A. Relationship between Constipation Predominant Irritable Bowel Syndrome and Menstruel Cycle Hormones. Uludağ University, Faculty of Medicine, Bursa. Master Thesis. 2013. p.15
• Referans21 Williams EA, Nai X, Corfe BM. Dietary intakes in people with irritable bowel syndrome. BMC Gastroenteroloy 2011:11:1-7.
• Referans22 Shiotani A, Miyanishi T, Takahashi T. Sex differences in irritable bowel syndrome in Japanese university students. Journal of Gastroenterology 2006; 41:562-568.
• Referans23 Ligaarden SC, Lydersen S, Farup PG. Diet in subjects with irritable bowel syndrome: a cross-sectional study in the general population. BMC Gastroenterology 2012;12:61.
• Referans24 Williams EA, Stimpson J, Wang D, et al. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study. Alimentary Pharmacology & Therapeutics 2009;29:97-103.
• Referans25 Ligaarden SC, Axelsson L, Naterstad K, Lydersen S, Farup PG. A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial. BMC Gastroenterology 2010;10:16.
• Referans26 Pekcan G. Determination of nutritional status. Ankara: Ministry of Health Publication; 2011.
• Referans27 Bohn L, Storsrud S, Simren M. Nutrient intake in patients with irritable bowel syndrome compared with the general population. Neurogastroenterology & Motility 2013; 25:23-30.
• Referans28 Prescha A, Pieczynska J, Ilow R, et al. Assessment of dietary intake of patients with irritable bowel syndrome. Rocz Panstw Zakl Hig. 2009;60:185-189.
• Referans29 Baysal A. Nutrition. 12th edition. Ankara: Hatipoğlu Publisher; 2009.
• Referans30 Simren M, Mansson A, Langkilde AM, et al. Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion 2001;63:108-115.
• Referans31 Young P, Cash BD. Probiotic use in irritable bowel syndrome. Current Gastroenterology Reports 2006;8:321-326.
• Referans32 Dapoigny M, Stockbrugger RW, Azpiroz F, et al. Role of alimentation in irritable bowel syndrome. Digestion 2003;67:225-233.
• Referans33 Internet: Dieatry References Intake URL: http://www.webcitation.org/query?url=https%3A%2F%2Ffnic.nal.usda.gov%2Fsites%2Ffnic.nal.usda.gov%2Ffiles%2Fuploads%2Frecommended_intakes_individuals.pdf&date=2019-04-01 Access date: 01.04.2019.
• Referans34 Slavin JL. Position of the American Dietetic Association: health implications of dietary fiber. Journal of the American Dietetic Association 2008;108:1716-31.
• Referans35 Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130:1480-1491.
• Referans36 Miller V, Lea R, Agrawal A, Whorwell PJ. Bran and irritable bowel syndrome: the primary-care perspective. Digestive and Liver Disease 2006;38:737-740.
• Referans37 Bijkerk CJ, Muris JW, Knottnerus JA, Hoes AW, de Wit NJ. Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 2004;19:245-251.
• Referans38 Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. Journal of Gastroenterology and Hepatology 2010;25:252-258.
• Referans39 Thomson ABR, Shaffer EA. (Eds.). First principles of gastroenterology the basis of disease and an approach to management, Fourth Edition. Canada. Astra Pharmaceuticals, 2000. p. 254.
• Referans40 American Crohn's and Colitis Foundation. Inflammatory Bowel Disease and Irritable Bowel Syndrome Similarities and Differences. New York, 2014. p. 6-8.
• Referans41 Shepherd SJ, Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. Journal of the American Dietetic Association 2006;106:1631-1639.
• Referans42 Heizer WD, Southern S, McGovern S. The role of diet in symptoms of irritable bowel syndrome in adults: a narrative review. Journal of the American Dietetic Association 2009;109:1204-1214.